Denali Therapeutics Inc. earnings per share and revenue

DNLI earnings per share for the last quarter are -0.59 USD whereas the estimation was -0.70 USD which accounts for 16.01% surprise. Company revenue for the same period amounts to 0.00 USD despite the estimated figure of 10.00 M USD. Estimated earnings per share for the next quarter are -0.60 USD, and revenue is expected to reach 6.30 M USD. Also watch annual changes over time to get a bigger picture of DNLI earnings per share and revenue dynamics.